Heparin and Lignocaine ampoules (Pfizer)

Recalls for product correction - potential for incorrect products in packages

11 August 2017

Consumers and health professionals are advised that Pfizer, in consultation with the TGA, is undertaking recalls for product correction involving Heparin 5000 U/5 mL injection 50 pack (Batch A473, expiry date Feb 2019) and Lignocaine 50 mg/5 mL ampoules (Batch A313, expiry date Nov 2017) due to the potential for incorrect products in packages.

Details of both recalls can be found in the links below.